Response to letter entitled: Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: Concern for immortal time bias effect.

Ayman Al Jurdi Leela Morena Leonardo V Riella

Am J Transplant

Center for Transplantation Sciences, Massachusetts General Hospital, Boston, Maryland, USA; Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Maryland, USA; Harvard Medical School, Boston, Massachusetts, USA. Electronic address:

Published: March 2023

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907783	PMC
http://dx.doi.org/10.1016/j.ajt.2023.01.009	DOI Listing

Publication Analysis

Top Keywords

response letter

letter entitled

entitled tixagevimab/cilgavimab

tixagevimab/cilgavimab pre-exposure

pre-exposure prophylaxis

prophylaxis breakthrough

breakthrough infection

infection risk

risk vaccinated

vaccinated solid

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!